Dilation of remnant pancreatic duct after pancreaticoduodenectomy: Clinical implications and risk factors - A prospective Japanese multicenter cohort study

Dilation of remnant pancreatic duct after pancreaticoduodenectomy: Clinical implications and risk factors - A prospective Japanese multicenter cohort study - DAIMONJI-Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029662

Enrollment

200

Registered

2017-10-22

Start date

2017-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periampullary tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged 20 years or older who are required to perform pancreaticoduodenectomy 2) Patients with non-dilated pancreatic duct in a diameter of less than 3mm 3) Patients who are expected to survive more than 1 year. 4) Patients who have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 5)Patients in whom Documented agreement was obtained

Exclusion criteria

Exclusion criteria: 1) Patients who are required to perform concurrent resection of the liver 2) Patients with dilated pancreatic duct in a diameter of 3mm or more 3) Patients who are performed pancreaticoduodenectomy in an emergent setting 4) Patients who cannot use contrast-enhanced CT 5) Patients in whom a doctor judges inappropriate for this study population

Design outcomes

Primary

Measure	Time frame
1) The incident rate of the dilation of the remnant pancreatic duct a year after pancreaticoduodenectomy for periampullary tumors 2) Association between the dilation of the remnant pancreatic duct and pancreatic exo-and endocrine function, nutrition status, development of fatty liver.	—

Secondary

Measure	Time frame
1) Clarification of risk factors of the dilation of the remnant pancreatic duct 2) Time course of the dilation of the remnant pancreatic duct following pancreaticoduodenectomy	—

Countries

Japan

Contacts

Public ContactMasato Narita

Kyoto Medical Center Secretariat of DAIMONJI-Study

narinari@kuhp.kyoto-u.ac.jp075-641-9161

Outcome results